United States Apixaban Market Research Report Forecast 2017-2021

June 2017 | 138 pages | ID: U464CE71E81EN
S&P Consulting

Abstracts

The United States Apixaban Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Apixaban industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Apixaban market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:

Pfizer, Inc. (US)
Bayer Healthcare AG (Germany)
GlaxoSmithKline Plc. (UK)
Boehringer Ingelheim (Germany)
Sanofi S.A. (France)
Abbott India Limited (India)
Aspen Holdings (South Africa)
Bristol-Myers Squibb Company (US)
Eisai Inc. (US)

United States Apixaban Market: Product Segment Analysis

• Type 1
• Type 2
• Type 3

United States Apixaban Market: Application Segment Analysis

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 APIXABAN MARKET OVERVIEW

1.1 Product Overview and Scope of Apixaban
1.2 Apixaban Market Segmentation by Type
  1.2.1 United States Production Market Share of Apixaban by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Apixaban Market Segmentation by Application
  1.3.1 Apixaban Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Apixaban (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON APIXABAN INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES APIXABAN MARKET COMPETITION BY MANUFACTURERS

3.1 United States Apixaban Production and Share by Manufacturers (2015 and 2016)
3.2 United States Apixaban Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Apixaban Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Apixaban Manufacturing Base Distribution, Production Area and Product Type
3.5 Apixaban Market Competitive Situation and Trends
  3.5.1 Apixaban Market Concentration Rate
  3.5.2 Apixaban Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES APIXABAN PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Apixaban Production and Market Share by Type (2012-2017)
4.2 United States Apixaban Revenue and Market Share by Type (2012-2017)
4.3 United States Apixaban Price by Type (2012-2017)
4.4 United States Apixaban Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES APIXABAN MARKET ANALYSIS BY APPLICATION

5.1 United States Apixaban Consumption and Market Share by Application (2012-2017)
5.2 United States Apixaban Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES APIXABAN MANUFACTURERS ANALYSIS

6.1 Pfizer, Inc. (US)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 Bayer Healthcare AG (Germany)
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 GlaxoSmithKline Plc. (UK)
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 Boehringer Ingelheim (Germany)
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Sanofi S.A. (France)
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Abbott India Limited (India)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Aspen Holdings (South Africa)
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 Bristol-Myers Squibb Company (US)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 Eisai Inc. (US)
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 APIXABAN MANUFACTURING COST ANALYSIS

7.1 Apixaban Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Apixaban

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Apixaban Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Apixaban Major Manufacturers in 2015
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES APIXABAN MARKET FORECAST (2017-2021)

11.1 United States Apixaban Production, Revenue Forecast (2017-2021)
11.2 United States Apixaban Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Apixaban Production Forecast by Type (2017-2021)
11.4 United States Apixaban Consumption Forecast by Application (2017-2021)
11.5 Apixaban Price Forecast (2017-2021)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Apixaban
Table Classification of Apixaban
Figure United States Sales Market Share of Apixaban by Type in 2015
Table Application of Apixaban
Figure United States Sales Market Share of Apixaban by Application in 2015
Figure United States Apixaban Sales and Growth Rate (2011-2021)
Figure United States Apixaban Revenue and Growth Rate (2011-2021)
Table United States Apixaban Sales of Key Manufacturers (2015 and 2016)
Table United States Apixaban Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Apixaban Sales Share by Manufacturers
Figure 2016 Apixaban Sales Share by Manufacturers
Table United States Apixaban Revenue by Manufacturers (2015 and 2016)
Table United States Apixaban Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Apixaban Revenue Share by Manufacturers
Table 2016 United States Apixaban Revenue Share by Manufacturers
Table United States Market Apixaban Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Apixaban Average Price of Key Manufacturers in 2015
Figure Apixaban Market Share of Top 3 Manufacturers
Figure Apixaban Market Share of Top 5 Manufacturers
Table United States Apixaban Sales by Type (2012-2017)
Table United States Apixaban Sales Share by Type (2012-2017)
Figure United States Apixaban Sales Market Share by Type in 2015
Table United States Apixaban Revenue and Market Share by Type (2012-2017)
Table United States Apixaban Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Apixaban by Type (2012-2017)
Table United States Apixaban Price by Type (2012-2017)
Figure United States Apixaban Sales Growth Rate by Type (2012-2017)
Table United States Apixaban Sales by Application (2012-2017)
Table United States Apixaban Sales Market Share by Application (2012-2017)
Figure United States Apixaban Sales Market Share by Application in 2015
Table United States Apixaban Sales Growth Rate by Application (2012-2017)
Figure United States Apixaban Sales Growth Rate by Application (2012-2017)
Table Pfizer, Inc. (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer, Inc. (US) Apixaban Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer, Inc. (US) Apixaban Market Share (2012-2017)
Table Bayer Healthcare AG (Germany) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bayer Healthcare AG (Germany) Apixaban Production, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Healthcare AG (Germany) Apixaban Market Share (2012-2017)
Table GlaxoSmithKline Plc. (UK) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Plc. (UK) Apixaban Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Plc. (UK) Apixaban Market Share (2012-2017)
Table Boehringer Ingelheim (Germany) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Boehringer Ingelheim (Germany) Apixaban Production, Revenue, Price and Gross Margin (2012-2017)
Table Boehringer Ingelheim (Germany) Apixaban Market Share (2012-2017)
Table Sanofi S.A. (France) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Sanofi S.A. (France) Apixaban Production, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi S.A. (France) Apixaban Market Share (2012-2017)
Table Abbott India Limited (India) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Abbott India Limited (India) Apixaban Production, Revenue, Price and Gross Margin (2012-2017)
Table Abbott India Limited (India) Apixaban Market Share (2012-2017)
Table Aspen Holdings (South Africa) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Aspen Holdings (South Africa) Apixaban Production, Revenue, Price and Gross Margin (2012-2017)
Table Aspen Holdings (South Africa) Apixaban Market Share (2012-2017)
Table Bristol-Myers Squibb Company (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bristol-Myers Squibb Company (US) Apixaban Production, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb Company (US) Apixaban Market Share (2012-2017)
Table Eisai Inc. (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Eisai Inc. (US) Apixaban Production, Revenue, Price and Gross Margin (2012-2017)
Table Eisai Inc. (US) Apixaban Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Apixaban
Figure Manufacturing Process Analysis of Apixaban
Figure Apixaban Industrial Chain Analysis
Table Raw Materials Sources of Apixaban Major Manufacturers in 2015
Table Major Buyers of Apixaban
Table Distributors/Traders List
Figure United States Apixaban Production and Growth Rate Forecast (2017-2021)
Figure United States Apixaban Revenue and Growth Rate Forecast (2017-2021)
Table United States Apixaban Production Forecast by Type (2017-2021)
Table United States Apixaban Consumption Forecast by Application (2017-2021)